Volume 10, Issue 2

June 2011
(14) Review, (2) Editorial, (2) Uropathology, (1) Radiation Oncology, (3) Quality Of Life, (1) Article - Comment

Review

PSA: past, today and tomorrow
  • Levent Mert Günay
  • Sertaç Yazıcı
  • Haluk Özen
Bull Urooncol 2011; 10: 5-10
Current analysis of urinary biomarkers for prostate cancer
  • Faruk Yencilek
  • Hakan Koyuncu
Bull Urooncol 2011; 10: 11-16
Can prostate cancer be prevented?
  • İlkan Yüksel
  • Mustafa Kaplan
Bull Urooncol 2011; 10: 17-21
Does inhibition of inflammation help in preventing prostate cancer ?
  • Ali İhsan Arık
  • Ahmet Güdeloğlu
  • Cemil Uygur
Bull Urooncol 2011; 10: 22-26
The effect of trace elements in prostate cancer
  • İlker Çelen
  • Feriye Şenol
  • Talha Müezzinoğlu
Bull Urooncol 2011; 10: 27-32
Has DNA methylation any impact in prostate cancer diagnosis?
  • Buket Kosova
  • Rukiye Özel
  • Çağdaş Aktan
Bull Urooncol 2011; 10: 33-40
A critical analysis of surgical curative treatments options in localised prostate cancer: open, laparoscopic, and robotassisted radical prostatectomy
  • Ender Özden
  • Yakup Bostancı
  • Yarkın Kamil Yakupoğlu
Bull Urooncol 2011; 10: 47-50
Algorithmic approach to rising PSA after curative prostate cancer treatment
  • Levent Mert Günay
  • Şevket Tolga Tombul
  • Bülent Akdoğan
Bull Urooncol 2011; 10: 51-55
Could focal therapy in prostate cancer replace standard therapy in the future?
  • Saadettin Y. Eskiçorapçı
  • Cihan Toktaş
Bull Urooncol 2011; 10: 56-62
Neoadjuvant and adjuvant treatment modalities for prostate cancer
  • Erkan Erkan
  • Gökhan Toktaş
Bull Urooncol 2011; 10: 63-69
What is the evidence-based ideal treatment of clinical locally advanced (cT3) prostate cancer?
  • Asıf Yıldırım
  • Erem Kaan Başok
Bull Urooncol 2011; 10: 70-75
Hormonal treatment of metastatic prostate cancer: Today and future
  • Hasan Soydan
  • Kadir Baykal
Bull Urooncol 2011; 10: 76-81
Immunotherapy in prostate cancer
  • Murat Lekili
Bull Urooncol 2011; 10: 82-84
Are there any treatment option for metastatic prostate cancer refractory to docetaksel?
  • Yaşar Bedük
Bull Urooncol 2011; 10: 85-89

Radiation Oncology

Possible problems and solutions after radiation therapy for prostate cancer
  • Serdar Özkök
Bull Urooncol 2011; 10: 98-102

Article - Comment

  • Sezgin Bakırdere
  • Mehmet Korkmaz
Bull Urooncol 2011; 10: 117-118

About Journal

Forms

Useful Links

Applications